Analysts speculate that Swiss drugmaker Roche may pay up to $10bn to buy rest of Chugai, even as Japanese group denied it was reviewing such a plan Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,